CollPlant to Trial 3D Bioprinted Breast Implants in Breakthrough Animal Study
Regenerative medicine specialist CollPlant (NASDAQ: CLGN) has revealed that the 3D bioprinted breast tissues it’s developing are set to enter animal trials in the very near future.